文献速递冠心病

ISCHEMIA试验中血运重建方式对结局的影响

Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.
PubMed 文献 · J Am Coll Cardiol · 2023-11-11

ISCHEMIA试验比较稳定性冠心病侵入性策略与保守策略的缺血事件风险相似。本文分别分析接受PCI或CABG的侵入性治疗患者结局,发现CABG和PCI早期30天内心血管事件风险均高于保守治疗,但长期风险较低;CABG早期风险最高,主要源于方案定义的操作性心肌梗死。

要点

  • CABG后30天内主要结局事件风险显著高于保守治疗(HR 16.25),主要因操作性心梗。
  • PCI后30天内主要结局事件风险亦高于保守治疗(HR 2.99),但低于CABG。
  • 30天后CABG和PCI的主要结局风险均低于保守治疗(HR分别为0.63和0.66)。

核心结论

  • 在ISCHEMIA试验中,与保守策略相比,PCI和CABG早期血运重建与更高的早期心血管事件风险和更低的长期风险相关。
  • CABG后早期风险最高,归因于方案定义的操作性心肌梗死。

研究设计与样本

  • ISCHEMIA试验的事后分析,纳入接受侵入性策略并完成血运重建的患者,从血运重建时起分为INV-PCI组(n=1,500)和INV-CABG组(n=512),与保守治疗组(n=2,591)比较。
  • 主要结局为心血管死亡、方案定义的心肌梗死或不稳定心绞痛住院、心力衰竭或复苏性心脏骤停的复合终点。

主要发现

  • INV-CABG组中位随访2.85年,主要结局事件84/512(16.4%),其中48例(57.1%)发生在CABG后30天内,包括40例操作性心肌梗死。
  • INV-PCI组中位随访2.94年,主要结局事件147/1,500(9.8%),其中31例(21.1%)发生在PCI后30天内,包括24例操作性心肌梗死。
  • 保守治疗组中位随访3.2年,主要结局事件352/2,591(13.6%),其中22例(6.3%)发生在随机化后30天内。
  • 调整后主要结局风险在CABG和PCI后30天内均更高(HR分别为16.25 [95%CI: 11.44-23.07]和2.99 [95%CI: 1.97-4.53]),30天后更低(HR分别为0.63 [95%CI: 0.44-0.89]和0.66 [95%CI: 0.53-0.82])。

临床怎么用

  • 临床决策时需权衡血运重建的早期风险(尤其是CABG后操作性心梗)与长期获益。
  • 对于稳定性冠心病患者,PCI和CABG的长期缺血事件风险低于初始保守治疗。

局限性

  • 本研究为ISCHEMIA试验的事后分析,非随机比较PCI与CABG,可能存在选择偏倚。
  • 早期事件风险增加主要归因于方案定义的操作性心肌梗死,其临床意义需进一步解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, the risk of ischemic events was similar in patients with stable coronary artery disease treated with an invasive (INV) strategy of angiography and percutaneous coronary intervention (PCI) or surgical (coronary artery bypass grafting [CABG]) coronary revascularization and a conservative (CON) strategy of initial medical therapy. OBJECTIVES: The authors analyzed separately the outcomes of INV patients treated with PCI or CABG. METHODS: Patients without preceding primary outcome events were categorized as INV-PCI or INV-CABG from the time of revascularization. The ISCHEMIA primary outcome (composite of cardiovascular death, protocol-defined myocardial infarction or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest) was used. RESULTS: Among INV-CABG patients, primary outcome events occurred in 84 of 512 (16.4%) at a median follow-up of 2.85 years; 48 events (57.1%) occurred within 30 days after CABG, including 40 procedural MIs. Among INV-PCI patients, primary outcome events occurred in 147 of 1,500 (9.8%) at median follow-up of 2.94 years; 31 of which (21.1%) occurred within 30 days after PCI, including 24 procedural MIs. In comparison, 352 of 2,591 CON patients (13.6%) had primary outcome events at a median follow-up of 3.2 years, 22 of which (6.3%) occurred within 30 days of randomization. The adjusted primary outcome risks were higher after both CABG and PCI within 30 days (HR: 16.25 [95% CI: 11.44-23.07] and HR: 2.99 [95% CI: 1.97-4.53]) and lower thereafter (0.63 [95% CI: 0.44-0.89] and 0.66 [95% CI: 0.53-0.82]). CONCLUSIONS: In ISCHEMIA, early revascularization by PCI and CABG was associated with higher early risks and lower long-term risks of cardiovascular events compared with CON. The early risk was greatest after CABG, owing to protocol-defined procedural MIs.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Redfors B, Stone GW, Alexander JH, et al. Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. J Am Coll Cardiol. 2023. PMID: 37956961. doi:10.1016/j.jacc.2023.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。